Intocell
₩14,850
0
-₩20-0.13%Tuesday 06:30
Statistics
Day High
0
Day Low
0
52W High
74,900
52W Low
13,050
Volume
0
Avg. Volume
39,017
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
IntoCell, Inc. develops protein-drug conjugates for the treatment of cancer. It develops antibody drug conjugates (ADC), fusion albumin drug conjugates, and triple conjugates. The company also develops B7-H3 ADC, which is in preclinical Phase for the treatment of solid cancers, as well as HER3 ADC, 5T4 ADC, and PSMA ADC for solid cancers. In addition, it develops Ortho-Hydroxy Protected Aryl Sulfate (OHPAS), a novel self-immolative group that designs to incorporate various functional groups for linking targeting moieties; and OHPASM Linker-toxin Library, an optimized linker-toxin library for fast delivery of a pre-clinical candidate in novel ADC programs. The company was founded in 2015 and is based in Daejeon, South Korea.
Show More
CEO
Mr. Tae-Kyo Park
Country
South Korea
ISIN
KR7287840003
Listings
0 Comments
Share your thoughts
FAQs
What is Intocell stock price today?▼
The current price of 287840.KQ is ₩14,850 KRW — it has decreased by -0.13% in the past 24 hours. Watch Intocell stock price performance more closely on the chart.
What is Intocell stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange Intocell stocks are traded under the ticker 287840.KQ.
Is Intocell stock price growing?▼
287840.KQ stock has fallen by -8.9% compared to the previous week, the month change is a -17.73% fall, over the last year Intocell has showed a -75.58% decrease.
In which sector is Intocell located?▼
Intocell operates in the Other sector.
When did Intocell complete a stock split?▼
Intocell has not had any recent stock splits.
Where is Intocell headquartered?▼
Intocell is headquartered in Daejeon, South Korea.